E-DRUG: COVID-19 & risks to the supply & quality of tests, drugs, & vaccines
-------------------------------------------------------------------------------
Dear Colleagues,
A note that a Comment: 'COVID-19 and risks to the supply and quality of tests, drugs, and vaccines' has been published in Lancet Global Health
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30136-4/fulltext
We hope that this helps precipitate coordinated global planning for ensuring access and quality for all essential medical products and for those that will, hopefully, be soon available for COVID-19. Please do share with policy makers with a request that this public health issue is not neglected, and that planning starts now whilst there is still time to prepare.
Please see links in the paper to French and Spanish translations.
Very best wishes,
Paul Newton & Kate Bond
Medicine Quality Research Group - Infectious Diseases Data Observatory (IDDO) & Mahidol Oxford Research Unit (MORU), University of Oxford, UK
Network Strategies for Health, North Bethesda, MD, UDA
Paul Newton <Paul.Newton@tropmedres.ac>